Hey nutcrackers 🌰 — today’s Nuts is a rich mix: Broadcom scoring Walmart 🏭, J&J flexing its pharma pipeline 💊, and Figma tripping on its way out of IPO hype 🎨. Plus, OpenAI’s mega India plans, Google dodging breakups, and Congress trying (again) to look ethical👀.

Grab your Nuts, let’s get cracking.

🏭 Broadcom Bags Walmart: From Checkout to Cloud

“When your chips aren’t enough, sell the whole kitchen.”

Broadcom (NASDAQ: $AVGO) just locked in Walmart as a flagship client. The retail giant will roll out VMware Cloud Foundation across global ops — think supply chains, stores, and digital services running on one sleek private cloud + edge network.

Why it matters: Broadcom’s $69B VMware bet was mocked as expensive bloat. Now? It’s validation. Anchoring the world’s biggest retailer proves AVGO is more than chips — it’s mission-critical software.

Investor Angle: Hardware = boom-bust cycles. Software = recurring revenue + juicy margins. Walmart’s nod tells Wall Street Broadcom’s moat is widening.

👉 Investor Takeaway: If Walmart’s rollout scales smoothly, expect more giants to follow. AVGO trades at $297 with a 0.79% yield.

💊 Johnson & Johnson’s Pipeline Punches Above Its Weight

“A pipeline within a pipeline.”

Johnson & Johnson (NYSE: $JNJ) is stacking late-stage wins — from autoimmune therapy Imaavy (nipocalimab) to bladder cancer candidate TAR-200 and psoriasis pill icotrokinra.

The flex:

• Cancer portfolio (Carvykti, Tecvayli, Talvey) pulled $1.3B in H1 2025.

• Neuroscience boosted via Intra-Cellular buy (Caplyta antidepressant).

• Management sees 10 drugs with $5B+ peak potential each.

Investor Angle: J&J is shifting from a defensive stock to a diversified medicine powerhouse.

👉 Investor Takeaway: Less Band-Aid, more blockbuster. JNJ trades at $178 with a 2.93% yield.

🎨 Figma Drew a Crowd, Then Tripped on the Exit

“Designers love it. Investors? Not so sure.”

Figma ($FIG) delivered its first post-IPO report:

• Revenue up 41% (~$249.6M).

• Small profit.

• Q3 + full-year guidance beat.

So why did the stock slip? Growth is decelerating post-Dev Mode hype, lockup expirations are looming, and this tape wants “blowout” — not “solid.”

The good: Net retention 129%, enterprise adoption rising, AI tools (Make), Sites rollout.
The bad: Multiple expansion capped until AI monetization proves sticky.

👉 Investor Takeaway: Great company, jittery stock. Scale in on red days if you believe CFOs will love it as much as designers do.

Together With Belay

Cut Costs. Not Corners.

Economic pressure is rising,  and doing more with less has become the new reality. But surviving a downturn isn’t about stretching yourself thinner; it’s about protecting what matters most. 

BELAY matches leaders with fractional, cost-effective support — exceptional Executive Assistants, Accounting Professionals, and Marketing Assistants — tailored to your unique needs. When you're buried in low-level tasks, you lose the focus, energy, and strategy it takes to lead through challenging times. 

BELAY helps you stay ready for whatever comes next.

📰 Other Nuts You Should Crack

• 🏗️ OpenAI goes giga in India: Planning a 1 GW data center under Project Stargate. Could be one of India’s biggest. Sam Altman may announce it on his visit.

• 📜 Congress trading ban revival: Bipartisan bill seeks to bar members & families from stock trading amid insider suspicions. Will it pass? History says: doubtful.

• 🔍 Google’s antitrust slap: Judge ruled Google runs an illegal monopoly in search, but no Chrome breakup. Stock popped +9%.

• 🔗 Galaxy tokenizes itself: Galaxy ($GLXY) will put real SEC-registered shares on-chain — first ever for a public company.

• 🌐 Google outage in Europe/Turkey: YouTube + services briefly down, forcing some back to Bing (ouch).

• 💸 Crypto adoption surges: India + U.S. lead globally, APAC on-chain activity up 69% YoY.

• 💵 Tariff refund bombshell: Court ruling could force U.S. Treasury to return $200B if Trump-era tariffs ruled unlawful.

• 📦 Amazon tightens Prime: Ending benefit-sharing outside households Oct 1. Analysts see a possible fee hike in 2026.

💡What else are we reading and seeing?

• Bankers prep for the busiest U.S. IPO week of 2025

• Walmart-backed OnePay adds wireless service

• OpenAI boosts secondary share sale to $10.3B

• Global bond selloff deepens, long-duration debt leads losses

• Starbucks fall menu drives record sales as PSL season returns

• Figma's stock plunges after company's first earnings report since IPO

• Long-end Treasury yields push toward 5% amid global bond retreat

• Goldman fights $11.9M claim from manager who won paternity-leave suit

🌰 That’s a Wrap

From Broadcom cloud flexes to J&J’s pharma power-ups and Figma’s IPO stumble — today’s market proves: growth stories are never simple.

Thanks for cracking open Cash Nut 🥜 with us today. See you tomorrow with more markets, money, and mischief.